Welcome to LookChem.com Sign In|Join Free

CAS

  • or

11121-32-7

11121-32-7

Post Buying Request

11121-32-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

11121-32-7 Usage

Uses

antifungal, antiprotozoal

Check Digit Verification of cas no

The CAS Registry Mumber 11121-32-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,1,1,2 and 1 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 11121-32:
(7*1)+(6*1)+(5*1)+(4*2)+(3*1)+(2*3)+(1*2)=37
37 % 10 = 7
So 11121-32-7 is a valid CAS Registry Number.

11121-32-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Mepartricin

1.2 Other means of identification

Product number -
Other names MEPARTRICIN

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:11121-32-7 SDS

11121-32-7Upstream product

11121-32-7Downstream Products

11121-32-7Related news

A double-blind study of the effects of MEPARTRICIN (cas 11121-32-7) in the treatment of obstruction due to benign prostatic hyperplasia07/21/2019

A double-blind, randomized, comparative study of mepartricin (SPA-S-160) and placebo was performed on 36 patients who complained of obstructive symptomatology caused by prostatic hypertrophy. Treatment was continued for 60 days at a dose of 150,000 IU/d (three capsules/d) of active substance. Al...detailed

Role of MEPARTRICIN (cas 11121-32-7) in category III chronic nonbacterial prostatitis/chronic pelvic pain syndrome: a randomized prospective placebo-controlled trial07/19/2019

ObjectivesTo verify the efficacy of mepartricin versus placebo with regard to symptom improvement in patients with chronic nonbacterial prostatitis/chronic pelvic pain syndrome (CPPS) and to verify a relation between hormonal levels and clinical improvement in these patients.detailed

Effects of MEPARTRICIN (cas 11121-32-7) on estradiol and testosterone serum levels and on prostatic estrogen, androgen and adrenergic receptor concentrations in adult rats07/18/2019

The effects induced by oral administration of 0, 5 and 20 mg of meparticin kg−1of body weight for 28 days (group 1, 2 and 3, respectively) upon prostatic estrogen, androgen, α1- andβ -adrenergic receptor concentrations and on estradiol and testosterone serum levels in adult male rats were stud...detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 11121-32-7